Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2025
|
Lucas Montarce EVP & CFO |
BUY
Open market or private purchase
|
Direct |
715
+4.64%
|
$494,065
$691.79 P/Share
|
|
Aug 13
2025
|
Ralph Alvarez Director |
BUY
Open market or private purchase
|
Indirect |
758
+50.0%
|
$500,280
$660.25 P/Share
|
|
Aug 13
2025
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
BUY
Open market or private purchase
|
Direct |
1,000
+4.64%
|
$647,000
$647.36 P/Share
|
|
Aug 12
2025
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
BUY
Open market or private purchase
|
Direct |
1,000
+0.72%
|
$634,000
$634.4 P/Share
|
|
Aug 12
2025
|
David A Ricks President, Chair, and CEO |
BUY
Open market or private purchase
|
Direct |
1,632
+0.3%
|
$1,051,008
$644.77 P/Share
|
|
Aug 12
2025
|
J Erik Fyrwald Director |
BUY
Open market or private purchase
|
Direct |
1,565
+1.04%
|
$1,004,730
$642.3 P/Share
|
|
Aug 12
2025
|
Gabrielle Sulzberger Director |
BUY
Open market or private purchase
|
Direct |
117
+4.15%
|
$74,997
$641.18 P/Share
|
|
Aug 11
2025
|
Ilya Yuffa EVP&Pres, LLY USA&Global Capab |
SELL
Open market or private sale
|
Direct |
1,250
-4.54%
|
$783,750
$627.01 P/Share
|
|
Aug 08
2025
|
Jamere Jackson Director |
BUY
Open market or private purchase
|
Direct |
200
+2.08%
|
$127,800
$639.56 P/Share
|
|
Aug 01
2025
|
Melissa Seymour EVP, Global Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-44.8%
|
$315,240
$740.07 P/Share
|
|
Aug 01
2025
|
Melissa Seymour EVP, Global Quality |
BUY
Exercise of conversion of derivative security
|
Direct |
952
+50.0%
|
-
|
|
Jul 24
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
280,000
-0.05%
|
$225,400,000
$805.95 P/Share
|
|
Jul 21
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,478
$762.18 P/Share
|
|
Jul 21
2025
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.23%
|
$4,572
$762.18 P/Share
|
|
Jul 21
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.65%
|
$9,906
$762.18 P/Share
|
|
Jul 21
2025
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,430
$762.18 P/Share
|
|
Jul 21
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$9,906
$762.18 P/Share
|
|
Jun 16
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.11%
|
$14,526
$807.58 P/Share
|
|
Jun 16
2025
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.23%
|
$4,842
$807.58 P/Share
|
|
Jun 16
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.61%
|
$9,684
$807.58 P/Share
|
|
Jun 16
2025
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.03%
|
$11,298
$807.58 P/Share
|
|
Jun 16
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$9,684
$807.58 P/Share
|
|
May 27
2025
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,000
-17.13%
|
$716,000
$716.41 P/Share
|
|
May 19
2025
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.23%
|
$4,530
$755.11 P/Share
|
|
May 19
2025
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,325
$755.11 P/Share
|
|
May 19
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$9,815
$755.11 P/Share
|
|
May 19
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.66%
|
$9,815
$755.11 P/Share
|
|
May 19
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,345
$755.11 P/Share
|
|
May 14
2025
|
Ilya Yuffa EVP&Pres, LLY USA&Global Capab |
SELL
Open market or private sale
|
Direct |
1,250
-4.35%
|
$936,250
$749.24 P/Share
|
|
May 02
2025
|
Anat Hakim EVP, GC & Secretary |
SELL
Bona fide gift
|
Direct |
17,875
-61.99%
|
-
|
|
Apr 21
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.11%
|
$14,724
$818.02 P/Share
|
|
Apr 21
2025
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.23%
|
$4,908
$818.02 P/Share
|
|
Apr 21
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$9,816
$818.02 P/Share
|
|
Apr 21
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.62%
|
$9,816
$818.02 P/Share
|
|
Apr 21
2025
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.03%
|
$11,452
$818.02 P/Share
|
|
Mar 17
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.1%
|
$14,008
$824.76 P/Share
|
|
Mar 17
2025
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.23%
|
$4,944
$824.76 P/Share
|
|
Mar 17
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$9,888
$824.76 P/Share
|
|
Mar 17
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.62%
|
$9,888
$824.76 P/Share
|
|
Mar 17
2025
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.03%
|
$11,536
$824.76 P/Share
|
|
Mar 13
2025
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,000
-14.62%
|
$818,000
$818.24 P/Share
|
|
Mar 03
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,000
-0.02%
|
$204,160,000
$928.71 P/Share
|
|
Mar 01
2025
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,260
-3.07%
|
$1,159,200
$920.63 P/Share
|
|
Mar 01
2025
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,837
+6.47%
|
-
|
|
Mar 01
2025
|
Eric Dozier EVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,066
-9.78%
|
$980,720
$920.63 P/Share
|
|
Mar 01
2025
|
Eric Dozier EVP, Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,403
+18.06%
|
-
|
|
Feb 25
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
225,000
-0.02%
|
$203,625,000
$905.96 P/Share
|
|
Feb 24
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
60,432
-0.0%
|
$3,588,814,752
$59386.22 P/Share
|
|
Feb 21
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
99,452
-0.01%
|
$88,015,020
$885.59 P/Share
|
|
Feb 20
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
14,685
-0.0%
|
$12,893,430
$878.84 P/Share
|